1 Leschziner, A. E., "Visualizing flexibility at molecular resolution:analysis of heterogeneity in single-particle electron microscopy reconstructions" 36 : 43-62, 2007
2 Strauss, S., "Up to 100-fold speed-up and multiplexing in optimized DNA-PAINT" 17 : 789-791, 2020
3 Wisniewski, J. R., "Universal sample preparation method for proteome analysis" 6 : 359-362, 2009
4 Jennings, M. L., "Topography of membrane proteins" 58 : 999-1027, 1989
5 Lazar-Molnar, E., "The interchain disulfide linkage is not a prerequisite but enhances CD28 costimulatory function" 244 : 125-129, 2006
6 Paul, M. D., "The RTK interactome: overview and perspective on RTK heterointeractions" 119 : 5881-5921, 2019
7 Ma, J., "Targeting of erbB3 receptor to overcome resistance in cancer treatment" 13 : 105-, 2014
8 Yu, X., "Targeting EGFR/HER2/HER3 with a three-in-one aptamer-siRNA chimera confers superior activity against HER2(+)breast cancer" 10 : 317-330, 2018
9 Rust, M. J., "Sub-diffraction-limit imaging by stochastic optical reconstruction microscopy (STORM)" 3 : 793-795, 2006
10 Lippincott-Schwartz, J., "Studying protein dynamics in living cells" 2 : 444-456, 2001
1 Leschziner, A. E., "Visualizing flexibility at molecular resolution:analysis of heterogeneity in single-particle electron microscopy reconstructions" 36 : 43-62, 2007
2 Strauss, S., "Up to 100-fold speed-up and multiplexing in optimized DNA-PAINT" 17 : 789-791, 2020
3 Wisniewski, J. R., "Universal sample preparation method for proteome analysis" 6 : 359-362, 2009
4 Jennings, M. L., "Topography of membrane proteins" 58 : 999-1027, 1989
5 Lazar-Molnar, E., "The interchain disulfide linkage is not a prerequisite but enhances CD28 costimulatory function" 244 : 125-129, 2006
6 Paul, M. D., "The RTK interactome: overview and perspective on RTK heterointeractions" 119 : 5881-5921, 2019
7 Ma, J., "Targeting of erbB3 receptor to overcome resistance in cancer treatment" 13 : 105-, 2014
8 Yu, X., "Targeting EGFR/HER2/HER3 with a three-in-one aptamer-siRNA chimera confers superior activity against HER2(+)breast cancer" 10 : 317-330, 2018
9 Rust, M. J., "Sub-diffraction-limit imaging by stochastic optical reconstruction microscopy (STORM)" 3 : 793-795, 2006
10 Lippincott-Schwartz, J., "Studying protein dynamics in living cells" 2 : 444-456, 2001
11 Kim, D. H., "Single particle tracking-based reaction progress kinetic analysis reveals a series of molecular mechanisms of cetuximab-induced EGFR processes in a single living cell" 8 : 4823-4832, 2017
12 Jaqaman, K., "Robust single-particle tracking in live-cell time-lapse sequences" 5 : 695-702, 2008
13 Black, P. C., "Receptor heterodimerization : a new mechanism for plateletderived growth factor induced resistance to anti-epidermal growth factor receptor therapy for bladder cancer" 185 : 693-700, 2011
14 DeFazio-Eli, L., "Quantitative assays for the measurement of HER1-HER2heterodimerization and phosphorylation in cell lines and breast tumors : applications for diagnostics and targeted drug mechanism of action" 13 : R44-, 2011
15 Paul, M. D., "Quantifying the strength of heterointeractions among receptor tyrosine kinases from different subfamilies:implications for cell signaling" 295 : 9917-9933, 2020
16 Sengupta, P., "Probing protein heterogeneity in the plasma membrane using PALM and pair correlation analysis" 8 : 969-975, 2011
17 Kanchanawong, P., "Nanoscale architecture of integrin-based cell adhesions" 468 : 580-584, 2010
18 Jungmann, R., "Multiplexed 3D cellular super-resolution imaging with DNA-PAINT and exchange-PAINT" 11 : 313-318, 2014
19 Ortiz-Zapater, E., "MET-EGFR dimerization in lung adenocarcinoma is dependent on EGFR mtations and altered by MET kinase inhibition" 12 : e0170798-, 2017
20 Nijkamp, M. M., "Interaction of EGFR with the tumour microenvironment : implications for radiation treatment" 108 : 17-23, 2013
21 Babu, M., "Interaction landscape of membrane-protein complexes in Saccharomyces cerevisiae" 489 : 585-589, 2012
22 Solomatin, S. V., "Implications of molecular heterogeneity for the cooperativity of biological macromolecules" 18 : 732-734, 2011
23 Betzig, E., "Imaging intracellular fluorescent proteins at nanometer resolution" 313 : 1642-1645, 2006
24 Kuninty, P. R., "ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer" 5 : eaax2770-, 2019
25 Wang, S. J., "Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer" 132 : 771-778, 2006
26 Wang, Q., "Gene expression profiling for diagnosis of triple-negative breast cancer : a multicenter, retrospective cohort study" 9 : 354-, 2019
27 Bjorkelund, H., "Gefitinib induces epidermal growth factor receptor dimers which alters the interaction characteristics with(1)(2)(5)I-EGF" 6 : e24739-, 2011
28 Sprague, B. L., "FRAP analysis of binding : proper and fitting" 15 : 84-91, 2005
29 Phillips, R., "Emerging roles for lipids in shaping membrane-protein function" 459 : 379-385, 2009
30 Kuwada, S. K., "Effects of trastuzumab on epidermal growth factor receptor-dependent and-independent human colon cancer cells" 109 : 291-301, 2004
31 De Robertis, M., "Dysregulation of EGFR pathway in EphA2 cell subpopulation significantly associates with poor prognosis in colorectal cancer" 23 : 159-170, 2017
32 Bhatia, S., "Different cell surface oligomeric states of B7-1 and B7-2 : implications for signaling" 102 : 15569-15574, 2005
33 Villalobos, V., "Current state of imaging proteinprotein interactions in vivo with genetically encoded reporters" 9 : 321-349, 2007
34 Jo, M., "Cross-talk between epidermal growth factor receptor and c-Met signal pathways in transformed cells" 275 : 8806-8811, 2000
35 Hsu, Y. F., "Complement activation mediates cetuximab inhibition of nonsmall cell lung cancer tumor growth in vivo" 9 : 139-, 2010
36 Reinmuth, N., "Combined anti-PDGFRalpha and PDGFRbeta targeting in non-small cell lung cancer" 124 : 1535-1544, 2009
37 Sun, R., "Cloning and expression of a novel target fusion protein and its application in anti-tumor therapy" 35 : 1877-1891, 2015
38 Yang, X., "Cetuximab-mediated tumor regression depends on innate and adaptive immune responses" 21 : 91-100, 2013
39 Song, N., "Cetuximab-induced MET activation acts as a novel resistance mechanism in colon cancer cells" 15 : 5838-5851, 2014
40 Uberall, I., "Cetuximab enhances the anti-proliferative effect of trastuzumab in ERBB2 over-expressing breast cancer cells-preliminary study" 24 : 356-360, 2011
41 Perez, A., "CD44 interacts with EGFR and promotes head and neck squamous cell carcinoma initiation and progression" 49 : 306-313, 2013
42 Grass, G. D., "CD147, CD44, and the epidermal growth factor receptor(EGFR)signaling pathway cooperate to regulate breast epithelial cell invasiveness" 288 : 26089-26104, 2013
43 Miernyk, J. A., "Biochemical approaches for discovering proteinprotein interactions" 53 : 597-609, 2008
44 Kerppola, T. K., "Bimolecular fluorescence complementation(BiFC)analysis as a probe of protein interactions in living cells" 37 : 465-487, 2008
45 Gottschalk, N., "Anti-epidermal growth factor receptor(EGFR)antibodies overcome resistance of ovarian cancer cells to targeted therapy and natural cytotoxicity" 13 : 12000-12016, 2012
46 Dorsch, S., "Analysis of receptor oligomerization by FRAP microscopy" 6 : 225-230, 2009
47 Kim, D. H., "Analysis of Interactions between the epidermal growth factor receptor and soluble ligands on the basis of single-molecule diffusivity in the membrane of living cells" 54 : 7028-7032, 2015
48 Larsen, A. B., "Activation of the EGFR gene target EphA2 inhibits epidermal growth factor-induced cancer cell motility" 5 : 283-293, 2007